...子治療]]、[[Monoclonal antibody/ja|モノクローナル抗体]]、[[cell therapy/ja|細胞治療]]（[[stem cell/ja|幹細胞]]治療など）を含むバイオ医薬品の区別である。その他、作用機序、[[route of administration|投与経路]]、影響を受
...a|IVIG]]など）、[[gene therappy/ja|遺伝子治療]]、[[cell therapy/ja|細胞治療]]（例えば、[[stem cell/ja|幹細胞]]治療）を含む）との間の分類である。
...
58 KB (1,845 words) - 17:09, 5 November 2023
...bodies]] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). Other ways to classify medicines are by mode of action, [[rou
...erapy]], and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies).
...
52 KB (6,923 words) - 17:09, 5 November 2023
...bodies]] and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies). Other ways to classify medicines are by mode of action, [[rou
...erapy]], and [[cell therapy|cell therapy]] (for instance, [[stem cell|stem cell]] therapies).
...
54 KB (7,245 words) - 17:08, 5 November 2023